Effect of Camrelizumab Combined with Concurrent Chemoradiotherapy in the Treatment of Middle and Advanced Esophageal Squamous Cell Carcinoma/GU Guangfu，LI Caihong.//Medical Innovationof China，2025，22(18)：135-138

    [Abstract] Objective： To explore the clinical effect of Camrelizumab combined with concurrent chemoradiotherapy in patients with middle and advanced esophageal squamous cellcarcinoma. Method： A total of 80 patients diagnosed with middleand advanced esophageal squamous cell carcinoma and admitted to the Second Affiliated Hospital of Xuzhou Medical University from May 2O2O to April2024 were selected.The patients were randomly divided intothe observation group and thecontrol group bythe computer digital table method，with 40 cases in each group. The control group received concurrent chemoradiotherapy，while the observation group was treated with Camrelizumabonthe basis ofthe control group.Theclinical eficacy，serum tumor markerlevels and the occurence of adverse reactions between the two groups were compared. Result： The disease control rate and objective effectiveratein theobservationgroup were both higherthan those inthecontrol group ......